OpenFilings

Enliven Therapeutics, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-03-14

Time Filed16:15:39

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.2
EX-10.3
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-97.1
Filing on SEC Edgar